UK Property & Short-Term Finance Insights
Alitalia accepts purchase offer from Italian State Railways (FS) | TornosNews.gr Tornos News International Edition
The government-appointed commissioners of Italian national airline Alitalia have accepted an offer from Italian State Railways (FS) to acquire Alitalia, beating …
Uber Allegedly Files for IPO in Step with Lyft Wccftech
Uber has apparently submitted its IPO filing at the same time as fierce competitor Lyft as both aim to float before markets turn.
AJ Bell hits the right note on its market debut Proactive Investors UK
A look at the day’s major movers, featuring AJ Bell, Genus, CyanConnode, EVR Holdings, Quadrise Fuels and ImmuPharma.
FTSE 100 closes higher on day after dreadful week for European benchmarks Proactive Investors UK
“A collective sigh of relief was felt across Oil markets after OPEC+ delegates successfully reached an agreement to cut production by 1.2 million barrels per day,” …
Developer inks deal with bank for RM100mil bridging loan – Metro News The Star Online
MELAKA-based property developer Tanjung Ratna Sdn Bhd has signed an agreement for a RM100mil bridging loan with Maybank Berhad to finance the …
FTSE 100 clings on to triple-digit gain despite expectations of a soft start on Wall Street Proactive Investors UK
While UK stocks are on the up, US stocks were expected to open lower. Axi Trader was calling the Dow Jones to open down 153 at 24795 and the S&P down 16 …
AJ Bell hits the right note on its market debut Proactive Investors UK
A look at the day’s major movers, featuring AJ Bell, Genus, CyanConnode, EVR Holdings, Quadrise Fuels and ImmuPharma.
Proactive news snapshot: ImmuPharma, Eurasia Mining, Tower Resources … Proactive Investors UK
A glance at some of the day’s highlights from the Proactive Investors newswire.
AJ Bell hits the right note on its market debut Proactive Investors UK
A look at the day’s major movers, featuring Genus, CyanConnode, EVR Holdings, Quadrise Fuels and ImmuPharma.
ImmuPharma making progress with its managed access programme for Lupuzor Proactive Investors UK
A look at the day’s major movers, starting with ImmuPharma, which is developing a treatment for the auto-immune disease, Lupus.